Patent ID: 9315539
Filing Date: 2016-04-19
CPC Classification: A61K,C07J

Claim Text:
1. A method of treating the symptomology of menopause in a patient while reducing the risk that the patient develops an estrogen-sensitive cancer, the method comprising administering to said patient an effective amount of a selective estrogen receptor modulator (SERM) which has the chemical structure: Where R is a sidechain group of at least 5 non-hydrogen atoms in length selected from a group, a group, a group, or a —(CH 2 ) n XR 4 group, R R X is O or S and Y is O; and n is from 1 to 3, wherein said symptomology is one or more of bone loss associated with osteoporosis, elevated cholesterol or elevated low-density lipoproteins (LDL), wherein said compound is other than compound E11-2,2Rev of Table 1 and